Observational studyPloS one2024

One-year experience with latanoprostene bunod ophthalmic solution 0.024% in clinical practice: A retrospective observational study.

Chun-Mei Hsueh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.